Esperto Medical
Developer of a noninvasive, wearable ultrasound-based method for continuous, calibration-free blood pressure measurement and multi-parameter cardiovascular monitoring. The company has published peer-reviewed validation, is conducting human studies (including pediatric), and is pursuing productization and clinical deployment for hospital, research, and low-resource settings.
Industries
Nr. of Employees
small (1-50)
Products
Calibration-free noninvasive continuous blood pressure monitoring device (wearable)
A wearable, wireless device that uses ultrasound/acoustic resonance to provide continuous blood pressure and additional cardiovascular metrics without calibration to an external reference.
Esperto Continuous Blood Pressure Monitor
A noninvasive, wireless, continuous blood pressure monitoring device using Resonance Sonomanometry™ technology that requires no calibration and provides accurate, real-time blood pressure data across all patient populations.
Calibration-free noninvasive continuous blood pressure monitoring device (wearable)
A wearable, wireless device that uses ultrasound/acoustic resonance to provide continuous blood pressure and additional cardiovascular metrics without calibration to an external reference.
Esperto Continuous Blood Pressure Monitor
A noninvasive, wireless, continuous blood pressure monitoring device using Resonance Sonomanometry™ technology that requires no calibration and provides accurate, real-time blood pressure data across all patient populations.
Services
On-site human-subject studies to compare investigational monitoring methods with standard devices; includes adult and pediatric volunteer recruitment.
Partnerships for advancing cardiovascular monitoring, device integration, and space-health adaptation.
On-site human-subject studies to compare investigational monitoring methods with standard devices; includes adult and pediatric volunteer recruitment.
Partnerships for advancing cardiovascular monitoring, device integration, and space-health adaptation.
Expertise Areas
- Continuous blood pressure measurement
- Wearable ultrasound devices
- Cardiovascular physiological monitoring
- Clinical validation and trial execution
Key Technologies
- Ultrasound-based arterial resonance sensing
- Wearable B-mode ultrasound imaging
- Acoustic resonance measurement
- Digital signal processing (DSP)
News & Updates
Company nominated in the Best Startup category for the 2025 Prix Galien USA.
Awarded a $50,000 grant from the Midwest Pediatric Device Consortium to extend noninvasive continuous vital sign monitoring technology for pediatric use.
Series A financing to support productization and clinical testing of the calibration-free, noninvasive continuous blood pressure technology.
Recognized as Octane's Best Emerging Disruptor of 2024.
Selected for the inaugural Space Health Accelerator to advance space-capable medical technologies.
Publication describing the patented acoustic resonance technique and initial clinical validation in humans.
Company nominated in the Best Startup category for the 2025 Prix Galien USA.
Awarded a $50,000 grant from the Midwest Pediatric Device Consortium to extend noninvasive continuous vital sign monitoring technology for pediatric use.
Series A financing to support productization and clinical testing of the calibration-free, noninvasive continuous blood pressure technology.
Recognized as Octane's Best Emerging Disruptor of 2024.
Selected for the inaugural Space Health Accelerator to advance space-capable medical technologies.
Publication describing the patented acoustic resonance technique and initial clinical validation in humans.